Postępy w Kardiologii Interwencyjnej

Periprocedural management of patients with hereditary angioedema undergoing coronary angiography and percutaneous coronary intervention

Michał Tarnowski 1
,
Paulina Brania 1
,
Iwona Gorczyca-Głowacka 2
,
Zbigniew Siudak 3, 4

  1. Department of Cardiology, Holy Spirit Specialist Hospital, Sandomierz, Poland

  2. Collegium Medicum, Jan Kochanowski University, Kielce, Poland

  3. Institute of Public Health, Jagiellonian University Medical College, Krakow, Poland

  4. Faculty of Medicine, Jan Kochanowski University, Kielce, Poland

Adv Interv Cardiol

DOI: https://doi.org/10.5114/aic.2026.164695
Data publikacji online: 2026/09/14
Article file
Periprocedural management.pdf
  1. Maurer M, Magerl M, Betschel S, et al. The international WAO/EAACI guideline for the management of hereditary angioedema. Allergy 2022; 77: 1961-90.
  2. Busse PJ, Christiansen SC. Hereditary angioedema. N Engl J Med 2020; 382: 1136-48.
  3. Zuraw BL, Banerji A, Bernstein JA, et al. US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema. J Allergy Clin Immunol Pract 2020; 8: 132-50.
  4. Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis and approach to treatment for angioedema. Allergy 2014; 69: 602-16.
  5. Maurer M, Magerl M. Long-term prophylactic therapy in hereditary angioedema. Immunol Allergy Clin North Am 2023; 43: 123-39.
  6. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023; 44: 3720-826.
  7. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87-165.
  8. Nasser A, Malkowski A, Żądło A, et al. Radial artery access in interventional cardiology: a review of current practices. Adv Interv Cardiol 2025; 21: 475-86.
  9. Tuner H, Kaya Y, Bingol G, et al. Flow-mediated dilatation facilitates transradial coronary angiography: a comparative study. Adv Interv Cardiol 2024; 20: 133-8.
  10. Farkas H, Zotter Z, Csuka D, et al. Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor: a long-term survey. Allergy 2012; 67: 1586-93.
  11. Banerji A. Current treatment of hereditary angioedema: an update on clinical studies. Allergy Asthma Proc 2010; 31: 398-406.
  12. Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 2012; 130: 692-7.
  13. Magerl M, Riedl MA, Arruda LK, et al. Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor. J Allergy Clin Immunol Glob 2025; 4: 100446.
  14. Uminski K, Goodyear D, Betschel S. Therapeutic advances in hereditary angioedema: a focus on present and future options. Adv Ther 2025; 42: 5879-95.
  15. Panayotov P, Mileva N, Vassilev D. Current challenges in coronary bifurcation interventions. Medicina 2024; 60: 1439.
  16. Yuan X, Nienaber S, Akin I, et al. Acute coronary syndromes: state-of-the-art diagnosis, management, and secondary prevention. J Clin Med 2025; 15: 16.
  17. Porębski G, Kucharczyk A, Matuszewski T, et al. Position statement of the hereditary angioedema Section of the Polish Society of Allergology on the management of hereditary angioedema due to C1 inhibitor deficiency: 2025 update. Part I: Classification, pathophysiology, clinical presentation, diagnosis, and differential diagnosis. Pol J Allergol 2025; 12: 153-62.
  18. Vázquez DO, Giavina-Bianchi P, Josviack D, et al. The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities. World Allergy Organization J 2026; 19: 101335.
  19. Wang C, Ramsey A, Lang D, et al. Management and prevention of hypersensitivity reactions to radiocontrast media: a consensus statement from the American College of Radiology and the American Academy of Allergy, Asthma & Immunology. Radiology 2025; 315: e240100.
  20. Van der Molen AJ, van de Ven AAJM, Vega F, et al. Hypersensitivity reactions to contrast media: Part 1. Management of immediate and non-immediate hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee. Eur Radiol 2025; 35: 6798-810.
  21. Cortellini G, Nakonechna A, Barbaud A, et al. Diagnosis and management of hypersensitivity to antiplatelet drugs: EAACI Position Paper. Allergy 2025; 80: 2973-87.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications